OTC Product: Zicam Cold and Flu Medicated Spoons

Olenak, Julie L.

doi:10.1331/1544-3191.46.6.e52.olenak

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Moreover, granules or pellets can be incorporated into medical devices to aid administration. This is the case of medicated spoons which contain a single-dose granulated formulation that can be designed to be either dispersed in a beverage prior to administration [59] or submerged in water to form an easy-to-administer pulp [25] . Another example of administration devices is the dose sipping technology in which a pre-dosed granulated medicine is filled into a ready-to-use straw ( Figure 3 ) [26] .…”

Section: Novel Approaches To Age-appropriate Oral Drug Deliverymentioning

confidence: 99%

Formulation approaches to pediatric oral drug delivery: benefits and limitations of current platforms

Lopez¹,

Ernest

Tuleu³

et al. 2015

Expert Opinion on Drug Delivery

211

147

View full text Add to dashboard Cite

Introduction: Most conventional drug delivery systems are not acceptable for pediatric patients as they differ in their developmental status and dosing requirements from other subsets of the population. Technology platforms are required to aid the development of age-appropriate medicines to maximize patient acceptability while maintaining safety, efficacy, accessibility and affordability. Areas covered: The current approaches and novel developments in the field of age-appropriate drug delivery for pediatric patients are critically discussed including patient-centric formulations, administration devices and packaging systems. Expert opinion: Despite the incentives provided by recent regulatory modifications and the efforts of formulation scientists, there is still a need for implementation of pharmaceutical technologies that enable the manufacture of licensed age-appropriate formulations. Harmonization of endeavors from regulators, industry and academia by sharing learning associated with data obtained from pediatric investigation plans, product development pathways and scientific projects would be the way forward to speed up bench-to-market age appropriate formulation development. A collaborative approach will benefit not only pediatrics, but other patient populations such as geriatrics would also benefit from an accelerated patient-centric approach to drug delivery.

show abstract

Section: Novel Approaches To Age-appropriate Oral Drug Deliverymentioning

confidence: 99%